Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

The treatment is safe and shows promise for metastatic breast cancer.

The model and estimator can predict drug exposure in kidney transplant patients well.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Best hair growth results from combining finasteride and minoxidil.

Patients follow treatment well, but many change medicines; good information helps compliance.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Methyl prednisolone helps most patients with alopecia universalis regrow hair.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Using finasteride and minoxidil together improves the frontal hairline best in male hair loss.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

A new treatment plan helps manage folliculitis decalvans effectively.

A quick method to measure minoxidil using a light-based titration technique was developed.

Combining FUE with rb-bFGF and minoxidil is more effective and has fewer side effects than FUE alone for treating hair loss.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

TPA is about 50 times more effective at promoting tumors than MZ.